CBD oil in MCT (10%)

Natural THC-free broad spectrum cannabidiol produced in Switzerland

This CBD oil dissolved in MCT oil contains 10 % broad spectrum cannabidiol (1000 mg CBD) extracted from certified Swiss hemp. The product is completely THC-free and combines CBD with MCT oil, which is an light-absorbing carrying oil, ideal for cosmetic skin care. The bottle comes with a medical pipette for easy and accurate application.

Benefits and effects

CBD oil dissolved in MCT oil adds essential fatty acids to the skin that is absorbed quickly and helps keep the skin balanced and moistened. MCT oil is known for its medium-length triglycerides that nourish the skin, while CBD can have a soothing effect that is well suited for dry or sensitive skin. Note: This product is only intended for cosmetic use and not for intake.

Ingredients and content

• Ingredients: MCT oil, broad spectrum CBD oil (1000 mg cannabidiol from Swiss hemp)
• Content per bottle: 10 ml, corresponding to approx. 270 drops
• THC content: 0.0 % - laboratory tested and confirmed THC -free

Manual

Shake the bottle well before use. Apply a few drops to the desired skin area morning and evening for optimal effect. For new users, it is recommended to start with a low dose to assess the skin's response. Store in a cool and dry place, protected from direct sunlight to preserve the quality.

Quality control and test results

We perform extensive tests on all our CBD products. Our CBD oil undergoes laboratory tests in Switzerland to ensure the right cannabinoid content and microbiological safety, as well as the absence of heavy metals, pesticides and other contaminants. We use biodegradable packaging from a British partner, who supports our environmentally friendly profile and contributes to a sustainable production chain.

Reservation

Only for adults over 18 years. Not recommended for pregnant or breastfeeding without medical approval. This product is intended for cosmetic use and not intended for oral administration. Uno Vita AS makes no medical claims about the effects of the product. We always recommend consulting health professionals before use if you have medical conditions or use prescription medications.

Freedom of speech and right to information

Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like in accordance with laws on freedom of speech. This includes:

• UN World Declaration of Human Rights (1948): Article 19
• The International Convention on Civil and Political Rights (1966): Article 19
• Norwegian Constitution § 100
• US First Amendment

Relevant references:

1. Huestis, M. A. (2007). Human cannabinoid pharmacokinetics.
2. Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids.
3. Mechoulam, R., & Parker, L. A. (2013). The Endocannabinoid System and the Brain.
4. Russo, E. B. (2011). Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects.
5. Pertwee, R. G. (2006). Cannabinoid pharmacology.
6. Pisanti, S., et al. (2017). Cannabidiol: State of the Art and New Challenges for Therapeutic Applications.
7. McPartland, J. M., et al. (2015). Cannabidiol modulation of the endocannabinoid system.
8. Zuardi, A. W. (2008). Cannabidiol: A Drug With a Wide Spectrum of Action.
9. Pamplona, ​​F. A., et al. (2018). The anti-inflammatory properties of cannabidiol.
10. Shannon, S., et al. (2019). Cannabidiol in anxiety and sleep.
11. Ashton, C. H. (2001). Effects of cannabis: A brief review.
12. Pertwee, R. G., et al. (2018). Cannabinoids in health and disease.